Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study

Clinical trial NCT07389525 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07389525
Sponsor: Indiana University
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Gastrointestinal Neoplasms Genitourinary Cancer Thoracic Cancer Sarcoma Melanoma

Start date: 2026-09-01
Primary completion: 2027-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.